Lawsuit on Behalf of Investors in Fusion-IO, Inc. (FIO)

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Lawsuit on Behalf of Investors in Fusion-IO, Inc. (FIO) Announced by Shareholders Foundation

SAN DIEGO, Dec. 11, 2013 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit was filed on behalf of certain purchasers of Fusion-IO, Inc. (FIO) common stock over alleged violations of Federal Securities Laws by Fusion-IO, Inc. in connection with certain allegedly false and misleading statements made between August 10, 2012 and October 23, 2013.

If you purchased a significant amount of shares of Fusion-IO, Inc. (FIO) between August 10, 2012 and October 23, 2013, and / or if you purchased FIO shares in 2012 or earlier and currently hold any of those shares, you have certain options and for certain investors are short and strict deadlines running. Deadline: January 21, 2014. Fusion-IO, Inc. investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The plaintiff alleges that the defendants misrepresented to investors that Fusion-IO, Inc. was a market leader in large-scale flash memory applications and was not facing any competitive pressure or risk from the commoditization of flash memory products, that defendants also issued positive revenue guidance and misrepresented that Fusion-IO, Inc. was able to anticipate the demand from its strategic customers based on its years of experience as their flash memory supplier, and that as a result of defendants' statements and omissions, Fusion-IO's securities traded at artificially inflated prices between August 10, 2012 and October 23, 2013.

On October 23, 2013, Fusion-IO, Inc. reported its fiscal first quarter 2014 results. Among other things, Fusion-IO, Inc. announced that its chief financial officer and executive vice president is leaving the Company and that its chief sales officer and executive vice president is retiring from the company.

Shares of Fusion-IO, Inc. (FIO) declined from $14.15 per share on October 21, 2013, to $9.46 per share on October 25, 2013.

The plaintiff seeks to recover damages on behalf of all purchasers of Fusion-IO, Inc. common stock between August 10, 2012 and October 23, 2013

Those who purchased shares of Fusion-IO, Inc. have certain options and should contact the Shareholders Foundation, Inc. by e-mail at mail@shareholdersfoundation.com or call +1 (858) 779-1554.

The Shareholders Foundation, Inc. is a professional portfolio legal monitoring and settlement claim filing service, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

Shareholders Foundation, Inc. Trevor Allen +1 (858) 779-1554 3111 Camino Del Rio North Suite 423 San Diego, CA 92108

Scroll down for more posts ▼

Top 10 Most Recent News Articles

UMC and AP Memory Boost Power with New AI Chips

Updated Category News Views 0

Breaking Ground in Data Center Power Every so often, the tech industry gets a jolt of innovation that turns heads—not just for what it can do today, but for what it promises tomorrow. This time, it's United Microelectronics Corporation (UMC) and AP Memory shaking things up with their collaboration aimed at redefining power delivery for AI and high-performance computing...

Continue Reading
Fosun Drives Global Growth of China's Drug Innovations

Updated Category News Views 6

A New Phase for Chinese Pharmaceuticals There's a shift in the pharma world, with Fosun International leading the charge. Chinese innovative drugs are stepping onto the global stage, thanks to efforts like those of Chen Qiyu, Co-CEO of Fosun. At the Sustainability Global Leaders Conference 2026, he spoke about transforming Chinese market players into worldwide...

Continue Reading
FirstService Ups the Ante with Stylish Jacksonville Office

Updated Category News Views 7

A New Chapter for FirstService Residential Picture this: a property management powerhouse dialing up their Jacksonville operations with a shiny new office move. FirstService Residential, North America's big shot in property management, has swapped location to a swish setup on Southpoint Drive South in Jacksonville, Florida, aiming to supercharge collaboration and give a...

Continue Reading
Verda & Compal Expand AI Infrastructure Globally

Updated Category News Views 5

AI Infrastructure Takes Center Stage Grab your coffee because Verda and Compal are shaking up the AI scene with their latest announcement from GTC Berlin 2026. The duo's expanding their collaboration, and if you're watching the markets, this isn't something you can ignore. With Verda's AI cloud muscle and Compal's beefed-up global manufacturing, we're talking about a...

Continue Reading
Compass Hit by Securities Fraud Suit; Investor Action Urged

Updated Category News Views 3

Trouble Brewing for Compass Investors Amidst Legal Storm In the tangled web of mergers and acquisitions, Compass, Inc. (NYSE: COMP) finds itself in a legal quagmire that has investors on edge. The stark reality of a securities fraud class action lawsuit has emerged, centered around Compass’s January 2026 merger with Anywhere Real Estate Inc. The Heart of the Allegations...

Continue Reading
How Track Rabbit Levels the Playing Field for Small Motorsport Ventures

Updated Category News Views 3

Fielding Opportunities in a Revved-Up Market You're knee-deep in grease and exhaust, keeping your motorsport enterprise alive against the big dogs without losing grip on the little guy's budget. What if I told you there's a service out there talking your language – combining marketing prowess with AI smarts for as low as $350 a month? That's ALIVE and Track Rabbit...

Continue Reading
RavenPack's Data Innovation: Sharpening Financial Analysis

Updated Category News Views 6

Innovating Financial Analysis with AI They said AI would change everything, but who knew it'd make such a wave in turning research ideas into actionable datasets? RavenPack's latest maneuver is rewriting the playbook. By leveraging a fine-tuned NVIDIA Nemotron model, they've managed to label a mind-boggling 845,220 financial-text excerpts in under an hour. It's not just...

Continue Reading
Heineken Hit with €111M Judgment—A Precedent Set

Updated Category News Views 7

A Brew of Legal Consequences for Heineken If this isn't a financial wake-up call for the brewing giant, I don't know what is. In the latest twist of corporate accountability, the Amsterdam District Court has ordered Heineken and its Greek subsidiary, Athenian Brewery, to cough up a whopping €111 million. And we're not just talking pocket change—this ruling speaks...

Continue Reading
Eightpoint Backs Community Shelter with Vital Aid

Updated Category News Views 3

Eightpoint Technologies Steps Up for a Crucial Cause Kicking in when it counts, Eightpoint Technologies has done something that might not turn stock market heads but speaks volumes about corporate responsibility. They're ponying up for a year's worth of groceries for the Cayman Islands Crisis Centre (CICC) starting November 1, 2026. We're talking real relief for women and...

Continue Reading
Bose Grabs Skullcandy: A Bold Audio Acquisition Move

Updated Category News Views 7

Bose Broadens Horizons with Skullcandy Acquisition Well, here's a twist that rattles my morning coffee mug: Bose goes and buys Skullcandy. That’s right, the audio bigwig known for polished sound just snapped up the edgier, younger sibling in earbuds. Bose ain't just playing with sound anymore; they're grabbing lifestyle by the horns, hoping Skullcandy's flair will shake...

Continue Reading

Top 5 Most Recently Viewed Articles

ISC Prepares for Upcoming Financial Results Announcement

Updated Category News Views 122

ISC Financial Results Upcoming Release ISC, a recognized leader in registry and information management, is set to unveil its financial results for the second quarter, concluding on June 30. Investors and stakeholders will have access to this key financial data on the designated date, which promises to highlight ISC's strategic developments and business performance. Key...

Continue Reading
Apache Software Foundation Celebrates 25 Years of Tomcat

Updated Category News Views 57

Apache Software Foundation Unveils Tomcat 11.0 Today, the Apache Software Foundation (ASF), a group of passionate volunteers dedicated to the advancement of open-source software, proudly announces the release of Apache Tomcat 11.0. This release not only introduces new features but also celebrates a significant milestone—the 25th anniversary of the first commit to the...

Continue Reading
Nona Biosciences and Umoja Biopharma Join Forces for CAR-T Advancements

Updated Category News Views 377

Nona Biosciences and Umoja Biopharma Collaborate to Advance CAR-T Therapies Nona Biosciences, recognized for its cutting-edge biotechnology solutions, has recently partnered with Umoja Biopharma in a significant collaboration. Their goal is to enhance CAR-T cell therapies, aiming to transform treatment options for patients affected by a range of oncological and autoimmune...

Continue Reading
Exciting Holiday Offers on Ruko 1088 Smart Robots for Kids

Updated Category News Views 101

Ruko Launches Special Black Friday Discounts on Their Smart Robots As the holiday season approaches, finding an ideal gift for children can be both exciting and challenging. The Ruko 1088 Smart Robot stands out as an exceptional choice, combining entertainment with education, making it perfect for kids this year. Ruko has initiated a special Black Friday promotion,...

Continue Reading
Eli Lilly's Positive Outlook: Key Developments and Ratings

Updated Category News Views 132

Deutsche Bank Sees Bright Future for Eli Lilly Deutsche Bank has recently affirmed its positive stance on Eli Lilly (NYSE: LLY), maintaining a Buy rating and setting a target price of $1,025.00. This optimistic outlook comes after the release of Phase 2a study results for Novo Nordisk's weight-loss drug, monlunabant, which fell short of expectations according to analysts....

Continue Reading